catalog number :
MBS9605476
products full name :
MYLIP Antibody
products short name :
[MYLIP]
products name syn :
[BM-023; BZF1; E3 ubiquitin protein ligase MYLIP; E3 ubiquitin-protein ligase MYLIP; Idol; Inducible degrader of the LDL-receptor; Lipoprotein receptor; MIR; MYLIP; MYLIP_HUMAN; Myosin regulatory light chain interacting protein; PP5242]
other names :
[E3 ubiquitin-protein ligase MYLIP; E3 ubiquitin-protein ligase MYLIP; E3 ubiquitin-protein ligase MYLIP; myosin regulatory light chain interacting protein; Inducible degrader of the LDL-receptor; Idol; Myosin regulatory light chain interacting protein; MIR; RING-type E3 ubiquitin transferase MYLIPCurated]
products gene name :
[MYLIP]
other gene names :
[MYLIP; MYLIP; MIR; IDOL; BZF1; IDOL; Idol; MIR]
reactivity :
Human, Mouse, Rat
specificity :
MYLIP antibody detects endogenous levels of total MYLIP
purity :
The antiserum was purified by peptide affinity chromatography using SulfoLink⢠Coupling Resin
form :
Liquid. Phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
storage stability :
Store at -20 degree C. Stable for 12 months from date of receipt.
tested application :
Western Blot (WB), Immunohistochemisty (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC), ELISA (EIA)
app notes :
WB: 1:500~1:1000. IHC: 1:50~1:200. IF/ICC: 1:100-1:500
image1 heading :
Immunohistochemistry (IHC)
image2 heading :
Western Blot (WB)
image3 heading :
Immunofluorescence (IF)
other info1 :
Immunogen: A synthesized peptide. Subcellular Location: Cytoplasm
products description :
Function:. E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of myosin regulatory light chain (MRLC), LDLR, VLDLR and LRP8. Activity depends on E2 enzymes of the UBE2D family. Proteasomal degradation of MRLC leads to inhibit neurite outgrowth in presence of NGF by counteracting the stabilization of MRLC by saposin-like protein (CNPY2/MSAP) and reducing CNPY2-stimulated neurite outgrowth. Acts as a sterol-dependent inhibitor of cellular cholesterol uptake by mediating ubiquitination and subsequent degradation of LDLR. Similarity:. The RING domain mediates ubiquitination and the neurite outgrowth inhibitory activity.The FERM domain binds phospholipids and mediates lipoprotein receptors recognition at the plasma membrane through their cytoplasmic tails.The RING-type zinc finger mediates the interaction with UBE2D E2 enzymes.
ncbi acc num :
NP_037394.2
ncbi gb acc num :
NM_013262.3
ncbi summary :
The ERM protein family members ezrin, radixin, and moesin are cytoskeletal effector proteins linking actin to membrane-bound proteins at the cell surface. Myosin regulatory light chain interacting protein (MYLIP) is a novel ERM-like protein that interacts with myosin regulatory light chain and inhibits neurite outgrowth. [provided by RefSeq, Jul 2008]
uniprot summary :
E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of myosin regulatory light chain (MRLC), LDLR, VLDLR and LRP8. Activity depends on E2 enzymes of the UBE2D family. Proteasomal degradation of MRLC leads to inhibit neurite outgrowth in presence of NGF by counteracting the stabilization of MRLC by saposin-like protein (CNPY2/MSAP) and reducing CNPY2-stimulated neurite outgrowth. Acts as a sterol-dependent inhibitor of cellular cholesterol uptake by mediating ubiquitination and subsequent degradation of LDLR.